FDA lifts clinical hold on three of Advaxis Inc’s experimental cancer therapies

The US Food and Drug Administration had lifted a clinical hold on Advaxis Inc’s 3 experimental cancer therapies, as per an announcement made by the drug developer on Wednesday. This has boosted the shares of the company by nearly 38%.

In October, the US health regulator had put the mid-... read more

FDA’s Approves a Drug to Reverse Effects of Deep Paralysis Caused Due To Muscle Relaxants

On Tuesday, the Food and Drug Administration (FDA) gave its approval to Merck & Co Inc.'s drug Bridion, used to reverse the effects of muscle relaxants used during surgery by doctors.

The drug genetically known as sugammadex can generate annual sales of $557 million by 2020, according... read more

Martin Shkreli is Back with His Usual Tricks to Raise Drug Prices

Martin Shkreli, financial and pharmaceutical executive with the title of America’s most hated man, is back with his well known tricks: rather than proving cost-effective medicines, Shkreli is hiking price of another drug. In a video, he can be seen saying that just 300 people in the US are with... read more

FDA Approves First Drug for Treating Overdose of Cancer Treatment

US regulators have given a green signal to the first and the only drug that can treat the overdose of chemotherapy or severe allergic reactions. The approval was based on clinical data that showed that overall survival rate of patients with 5-fluorouracil (5-FU) toxicity who received a single... read more

Alexion’s Drug Kanuma receives FDA Approval to Treat LAL-D

The US Food and Drug Administration (FDA) gave a green signal to Alexion Pharmaceutical Inc's drug on Tuesday to treat rare and fatal genetic disorder. On the same day, shares of the company were up 4.5% at $187.22.

Kanuma, enzyme-replacement therapy of Cheshire headquartered Alexion,... read more

Washington to receive $1.2 million in Medicaid reimbursement by Novartis

Washington has reached an agreement with Novartis Pharmaceuticals Corporation in its kickback scheme in order to promote its drug, Exjade. Attorney General Bob Ferguson said that the agreement forms to be part of a pending execution by the company.

The company would provide the state with... read more

Three Largest Pharmacy-Benefit Managers in the US cease Work with Philidor

United State’s three largest pharmacy benefit providers said on Thursday that they are breaking their ties with a pharmacy affiliated with Valeant Pharmaceuticals after a review of the pharmacy’s business practices.

CVS Health Corp. on Thursday said that it is terminating mail-order... read more

Pfizer Inc Had Early Talks with Allergan Plc to Discuss Takeover Deal

Pfizer Inc, an American multinational pharmaceutical corporation, has recently held talks with Allegran Plc to discuss takeover deal, which could be the biggest acquisition of this year, the Wall Street Journal and Financial Times reported.

The healthcare sector has seen several big and... read more

Two Drug Companies announce delay in shipping flu vaccines for children this season

Two drug companies have announced that there will be delays in shipping flu vaccines for children this season. MedImmune has announced delayed shipment of its FluMist nasal spray vaccine. And, Sanofi Pasteur also said that it is running behind its shipping schedule of pre-filled syringes of its... read more

Costly Turing Pharmaceuticals drug faces competition from Imprimis

Last month, Turing Pharmaceuticals led to a nationwide outrage and government investigations after it hiked the price of Daraprim, a drug for treating AIDS and cancer, from $13.50 a capsule to $750. San Diego’s biomedical company Imprimis Pharmaceuticals has introduced a competitor to the... read more

Shire planning to respond to FDA with OPUS-3 Trial

In an announcement Shire plc said that the company has been asked by the US Food and Drug Administration (FDA) for an additional clinical study in a complete response letter (CRL) to its new drug application for lifitegrast. The drug is used for the signs and symptoms of dry eye disease in... read more

US FDA Grants Approval to Cholesterol Drug Praluent

Friday saw the US Food and Drug Administration approve a drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for long. This drug named Praluent, is manufactured by Sanofi SA and Regeneron Pharmaceuticals Inc.

Friday's decision by the FDA followed a... read more


Popular Stories

Overall childhood ‘asthma epidemic’ levels off in U.S.

The overall ‘asthma epidemic’ among children has... Read More

‘UC Quits’ Working to Help California Smokers Get Rid Of Smoking

As New Year is approaching, people have already... Read More

Scientists begin Stem Cell research to find cure for Alzheimer’s

Alzheimer’s disease, the commonest cause of... Read More

New House Bill to Restrict First-Time Opioid Prescriptions

Cases of opioid abuse have been increasing and... Read More

Comcast installs DOCSIS 3.1 modem on customer-facing network in Philadelphia

In an announcement made on December 22, cable giant... Read More